PATHOLOGIC STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Modified virus tested to attack tough esophageal cancers
Disease control OngoingThis early-stage study is testing the safety of adding a specially designed virus (OBP-301) to standard chemotherapy and radiation for patients with advanced esophageal or gastroesophageal cancer who are not candidates for surgery. The virus is meant to infect and kill cancer cel…
Matched conditions: PATHOLOGIC STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New combo therapy aims to shrink tumors before esophageal cancer surgery
Disease control OngoingThis study is testing whether adding immunotherapy drugs to standard chemotherapy before surgery can better control cancer in the esophagus or where the stomach meets the esophagus. The goal is to shrink the tumor as much as possible before an operation to remove it. Researchers …
Matched conditions: PATHOLOGIC STAGE II ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC